Mubbasher Ameer Syed

Mubbasher Ameer Syed

Auto-generated profile, based on publicly available information

Mubbasher Ameer Syed

Cardiology, University of Toledo Medical Center, Toledo, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2019 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
KCKhalid Hamid Changal
Khalid Hamid Changal
MSMubbasher Ameer Syed
Mubbasher Ameer Syed
TDTawseef Dar
Tawseef Dar
MMMuhammad Asif Mangi
Muhammad Asif Mangi
MSMujeeb Abdul Sheikh
Mujeeb Abdul Sheikh
Introduction. Common femoral endarterectomy (CFE) has been the therapy of choice for common femoral artery atherosclerotic disease (CFA-ASD). In the past, there was inhibition to treat CFA-ASD endovascularly with stents due to fear of stent fracture and compromise of future vascular access site. However, recent advances and new evidence suggest that CFA may no longer be a ‘stent-forbidden zone’. In the light of new evidence, we conducted a meta-analysis to determine the use of endovascular treatment for CFA-ASD and compare it with common femoral endarterectomy in the present era.Methods. Using certain MeSH terms we searched multiple databases for studies done on endovascular and surgical treatment of CFA-ASD in the last two decades. Inclusion criteria were randomized control trials, observational, prospective, or retrospective studies evaluating an endovascular treatment or CFE for CFA-ASD. For comparison, studies were grouped based on the treatment strategy used for CFA-ASD: endovascular treatment with selective stenting (EVT-SS), endovascular treatment with routine stenting (EVT-RS), or common femoral endarterectomy (CFE). Primary patency (PP), target lesion revascularization (TLR), and complications were the outcomes studied. We did proportional meta-analysis using a random-effect model due to heterogeneity among the included studies. If confidence intervals of two results do not overlap, then statistical significance is determined.Results. Twenty-eight studies met inclusion criteria (7 for EVT-RS, 8 for EVT-SS, and 13 for CFE). Total limbs involved were 2914 (306 in EVT-RS, 678 in EVT-SS, and 1930 in CFE). The pooled PP at 1 year was 84% (95% CI 75-92%) for EVT-RS, 78% (95% CI 69-85%) for EVT-SS, and 93% (95% CI 90-96%) for CFE. PP at maximum follow-up in EVT-RS was 83.7% (95% CI 74-91%) and in CFE group was 88.3% (95% CI 81-94%). The pooled target lesion revascularization (TLR) rate at one year was 8% (95% CI 4-13%) for EVT-RS, 19% (95% CI 14-23%) for EVT-SS, and 4.5% (95% CI 1-9%) for CFE. The pooled rate of local complications for EVT-RS was 5% (95% CI 2-10%), for EVT-SS was 7% (95% CI 3 to 12%), and CFE was 22% (95% CI 14-32%). Mortality at maximum follow-up in CFE group was 23.1% (95% CI 14-33%) and EVT-RS was 5.3% (95% CI 1-11%).Conclusion. EVT-RS has comparable one-year PP and TLR as CFE. CFE showed an advantage over EVT-SS for one-year PP. The complication rate is lower in EVT RS and EVT SS compared to CFE. At maximum follow-up, CFE and EVT-RS have similar PP but CFE has a higher mortality. These findings support EVT-RS as a management alternative for CFA-ASD.

1 November 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Rajkumar DoshiRajkumar Doshi
Rajkumar Doshi
KCKhalid Hamid Changal
Khalid Hamid Changal
RGRajeev Gupta
Rajeev Gupta
JSJay Shah
Jay Shah
KPKrunalkumar Patel
Krunalkumar Patel
ASA. Mujeeb Sheikh
A. Mujeeb Sheikh

1 June 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
RSRamy Sedhom
Ramy Sedhom
PAPeter Abdelmaseeh
Peter Abdelmaseeh
MHMagued Haroun
Magued Haroun
MMMichael Megaly
Michael Megaly
MNMahesh Anantha Narayanan
Mahesh Anantha Narayanan
WJWissam A. Jaber
Wissam A. Jaber

16 April 2020 in Coronary Artery Disease
Verified
Journal Article
Closed access
SSSameer Saleem
Sameer Saleem
MSMubbasher Syed
Mubbasher Syed
AEAhmed Elzanaty
Ahmed Elzanaty
SNSalik Nazir
Salik Nazir
KCKhalid Changal
Khalid Changal
MSMujeeb Sheikh
Mujeeb Sheikh
Anomalous origin of right coronary artery with interarterial course (ARCA-IA) is a risk factor for sudden death and other cardiac complications. Surgical correction remains its gold standard treatment. We describe clinical characteristics, workup, surgical techniques and outcomes of ARCA-IA at our center. A retrospective analysis of cardiovascular database was performed. From March 2005 through January 2011, 11 patients with mean age of 53 ± 18 years were diagnosed with ARCA-IA. Reported symptoms included chest pain (64%), arrhythmia [27%; i.e. atrial flutter (9%), recurrent supraventricular tachycardia (9%), ventricular tachycardia (9%)], syncope (18%), dyspnea (9%) and aborted sudden cardiac death (9%). Chest pain (n = 7) was episodic and lasted longer than 6 months before diagnosis. Initial diagnosis was made at coronary computed tomography in two patients and at cardiac catheterization in nine patients. Four patients had positive stress test and were subsequently found to have ARCA-IA at cardiac catheterization. There was no operative mortality. Surgery (bypass with ligation of native vessel or translocation and reimplantation) was performed in seven patients. Three patients refused surgery, and in one patient, surgery was not considered due to comorbidities. Symptom relief was noted in all surgical patients. At mean follow-up of 36 months, two patients had noncardiac-related deaths whereas nine were asymptomatic. There were no deaths reported in patients treated surgically. Definitive surgery is indicated in symptomatic ARCA-IA and is associated with excellent long-term outcome. RCA dominance in ARCA-IA is an adverse marker with increased symptoms; this hypothesis should be tested in larger studies.

1 October 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SSSameer Saleem
Sameer Saleem
SYSundas Younas
Sundas Younas
MSMubbasher Ameer Syed
Mubbasher Ameer Syed

5 June 2017 in Cureus
Verified
Journal Article
Open access
PDF file
MSMurtaza Sundhu
Murtaza Sundhu
MSMubbasher Syed
Mubbasher Syed
SGSajjad Gul
Sajjad Gul
BSBilal Saqi
Bilal Saqi
RMRobert Mosteller
Robert Mosteller
Persistent left superior vena cava (PLSVC) is a rare disorder which is asymptomatic and hence is usually discovered while performing interventions through the left subclavian vein. We present a case of a 78-year-old male who was undergoing elective placement of a permanent pacemaker for tachycardia – bradycardia syndrome with post-conversion pauses of up to nine seconds. After achieving access through the left subclavian vein the wire kept on going on the left side of the chest instead of crossing the midline to the right side. The wire was removed and contrast venography was done, PLSVC with dilated coronary sinus emptying into the right atrium was confirmed. There was some difficulty in passing the lead to the right ventricle even with the acute curve in the stylet. The sheath size was increased and a longer deflectable sheath was used and with the tip of the lead anteriorly the right ventricle was cannulated and the lead was affixed. There were good sensing and pacing parameters. Post procedure chest x-ray was done and the patient was discharged without any complications.